Correlation Between Aquestive Therapeutics and Avis Budget

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Avis Budget at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Avis Budget into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Avis Budget Group, you can compare the effects of market volatilities on Aquestive Therapeutics and Avis Budget and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Avis Budget. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Avis Budget.

Diversification Opportunities for Aquestive Therapeutics and Avis Budget

0.14

Correlation Coefficient

Aquestive Therapeutics  Avis Budget

Average diversification

The 3 months correlation between Aquestive and Avis is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Avis Budget Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avis Budget Group and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Avis Budget. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avis Budget Group has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Avis Budget go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Avis Budget

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 1.66 times less return on investment than Avis Budget. In addition to that, Aquestive Therapeutics is 1.16 times more volatile than Avis Budget Group. It trades about 0.09 of its total potential returns per unit of risk. Avis Budget Group is currently generating about 0.18 per unit of volatility. If you would invest  7,531  in Avis Budget Group on August 31, 2024 and sell it today you would earn a total of  3,353  from holding Avis Budget Group or generate 44.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Aquestive Therapeutics  vs.  Avis Budget Group

Aquestive Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Avis Budget Group

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Avis Budget Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Avis Budget reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aquestive Therapeutics and Avis Budget

The main advantage of trading using opposite Aquestive Therapeutics and Avis Budget positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Avis Budget can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avis Budget will offset losses from the drop in Avis Budget's long position.

The idea behind Aquestive Therapeutics and Avis Budget Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.